Copyright © Inderes 2011 - present. All rights reserved.

OptiCept Technologies

1.71 SEK

+0.71 %

Less than 1K followers

OPTI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

+0.71 %
-25.65 %
-33.20 %
-47.22 %
-62.25 %
-62.62 %
-82.82 %
-96.66 %
-66.09 %

OptiCept Technologies provides the food and plant industry with technological solutions that are used to increase the sustainability of various raw materials. The company works with biological processes that provide increased extraction from the raw material, reduced waste and maintained taste, aroma, color, nutritional content. The company has a patented technology within PEF (pulsed electric field) and VI (Vacuum Infusion). The company sells its products on a global level. The headquarters are located in Lund.

Read more
Market cap
111.4M SEK
Turnover
43.54K SEK
Revenue
17.67M
EBIT %
-317.43 %
P/E
-
Dividend yield-%
-
Latest research

Latest analysis report

Released: 2024-12-02

Latest extensive report

Released: 2024-02-02

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
27/3
2026

Annual report '25

21/5
2026

General meeting '26

29/5
2026

Interim report Q1'26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Forum discussions
OptiCept Technologies develops and provides technological solutions specifically designed for the needs of the food and plant industries. The company’s technologies focus on improving the sustainability and utilization of raw materials, enabling more efficient production while reducing...
8/31/2024, 12:07 PM
by Sijoittaja-alokas
3
@lucas.mattsson on tehnyt uuden analyysin OptiCeptistä. The capital raise announced on Friday reduces the financing risks and secures the company’s financing until the end of 2025. Due to the overall structure of the raise, we expect it to succeed. With short-term financing in check...
10/21/2024, 4:24 PM
by Sijoittaja-alokas
1
Here are @lucas.mattsson’s comments on OptiCept’s capital raise preliminarily reaching 70 percent of their subscription target, which maintains the company’s cash flow at nearly the expected level. Inderes OptiCept’s capital raise preliminary outcome at 70% of maximum gross proceeds...
11/27/2024, 11:36 AM
by Sijoittaja-alokas
0
OptiCept has signed a rental agreement with the Central American company Mexifrutas for the rental of an OptiCept PEF system to enhance pineapple juice extraction. A successful evaluation period could lead to long-term cooperation and help expand OptiCept’s commercial operations ...
10/16/2024, 6:45 PM
by Sijoittaja-alokas
0
OptiCept on ilmoittanut, että sen asiakas La Salud on saanut taloudellista tukea EU:lta, mikä oli tärkeä edellytys aiemmin tiedotetun kahden OliveCept-järjestelmän tilauksen etenemiselle. Tässä olisi Lucaksen kommentit asiaan liittyen. OptiCept has announced that its customer, La...
9/18/2024, 1:54 PM
by Sijoittaja-alokas
0
Here are Lucas’s comments regarding the options. OptiCept has reached an agreement to bring forward the exercise period for all outstanding warrants, resulting in the subscription of 4,350,000 shares worth around 13 MSEK. We had previously flagged that this was a possibility, so ...
9/12/2024, 7:50 AM
by Sijoittaja-alokas
0
Here are Lucas Mattsson’s comments on OptiCept signing a letter of intent (LOI) with Saab to explore a long-term partnership in Thailand aimed at improving productivity in the food and forestry industries. The cooperation could lead to new orders and a wider commercial scale in the...
9/9/2024, 10:19 PM
by Sijoittaja-alokas
0
Read more on our forum
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.